Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell-mediated restoration of normal human chromosome 19

Genes Chromosomes and Cancer

Volumn 48, Issue 10, 2009, Pages 854-864

  Drucker, Kristen L ^a   Kitange, Gaspar J ^a   Kollmeyer, Thomas M ^a   Law, Mark E ^a   Passe, Sandra ^a   Rynearson, Amanda L ^a   Blair, Hilary ^a   Soderberg, Cheryl L ^a   Morlan, Bruce W ^a   Ballman, Karla V ^a   Giannini, Caterina ^a   Jenkins, Robert B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BCL2 LIKE 12; CALCIUM BINDING PROTEIN; CALMODULIN BINDING PROTEIN; CHROMOSOME PROTEIN; COILED COIL DOMAIN CONTAINING 8 PROTEIN; PROTEIN BCL 2; PROTEIN FLJ10781; RETICULOCALBIN 3; STRIATIN 4; SUMO 1 ACTIVATING ENZYME SUBUNIT 1; SUMO 1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CHROMOSOME 19; CHROMOSOME DELETION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC COMPLEMENTATION; GLIOMA; GLIOMA CELL; GROWTH RATE; HUMAN; HUMAN CELL; HYBRID CELL; MICROARRAY ANALYSIS; MICROSATELLITE MARKER; MOLECULAR PROBE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; CELL SHAPE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 19; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC TECHNIQUES; GLIOMA; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM;

EID: 70349310236     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20688     Document Type: Article

References (38)

1. Adachi J, Ohbayashi K, Suzuki T, Sasaki T. 1999. Cell cycle arrest and astrocytic differentiation resulting from PTEN expression in glioma cells. J Neurosurg 91:822-830. (Pubitemid 30053155)
2. Altman SA, Randers L, Rao G. 1993. Comparison of trypan blue dye exclusion and fluorometric assays for mammalian cell viability determinations. Biotechnol Prog 9:671-674. (Pubitemid 2022153)
3. Astbury C, Jackson-Cook CK, Culp SH, Paisley TE, Ware JL. 2001. Suppression of tumorigenicity in the human prostate cancer cell line M12 via microcell-mediated restoration of chromosome 19. Genes Chromosomes Cancer 31:143-155. (Pubitemid 32411040)
4. Ballman KV, Grill DE, Oberg AL, Therneau TM. 2004. Faster cyclic loess: Normalizing RNA arrays via linear models. Bioinformatics 20:2778-2786.
5. Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M. 2005. Allelic losses at 1p36 and 19q13 in gliomas: Correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Clin Cancer Res 11:1119-1128. (Pubitemid 40175761)
6. Bell HS, Whittle IR, Bader SA, Wharton SB. 2005. Discovery of a perinecrotic 60 kDa MDM2 isoform within glioma spheroids and glioblastoma biopsy material. Neuropathol Appl Neurobiol 31:191-202.
7. Burger PC, Minn AY, Smith JS, Borell TJ, Jedlicka AE, Huntley BK, Goldthwaite PT, Jenkins RB, Feuerstein BG. 2001. Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections. Mod Pathol 14:842-853.
8. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN. 1998. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473-1479. (Pubitemid 28482012)
9. Caskey LS, Fuller GN, Bruner JM, Yung WK, Sawaya RE, Holland EC, Zhang W. 2000. Toward a molecular classification of the gliomas: Histopathology, molecular genetics, and gene expression profiling. Histol Histopathol 15:971-981. (Pubitemid 30488576)
10. Cowell JK, Barnett GH, Nowak NJ. 2004. Characterization of the 1p/19q chromosomal loss in oligodendrogliomas using comparative genomic hybridization arrays (CGHa). J Neuropathol Exp Neurol 63:151-158.
11. Ecsedy JA, Holthaus KA, Yohe HC, Seyfried TN. 1999. Expression of mouse sialic acid on gangliosides of a human glioma grown as a xenograft in SCID mice. J Neurochem 73:254-259.
12. Fallon KB, Palmer CA, Roth KA, Nabors LB, Wang W, Carpenter M, Banerjee R, Forsyth P, Rich K, Perry A. 2004. Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas. J Neuropathol Exp Neurol 63:314-322. (Pubitemid 38429028)
13. Felsberg J, Erkwoh A, Sabel MC, Kirsch L, Fimmers R, Blaschke B, Schlegel U, Schramm J, Wiestler OD, Reifenberger G. 2004. Oligodendroglial tumors: Refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival. Brain Pathol 14:121-130. (Pubitemid 38656383)
14. Gagnon A, Ripeau JS, Zvieriev V, Chevrette M. 2006. Chromosome 18 suppresses tumorigenic properties of human prostate cancer cells. Genes Chromosomes Cancer 45:220-230. (Pubitemid 43238473)
15. Golembieski WA, Ge S, Nelson K, Mikkelsen T, Rempel SA. 1999. Increased SPARC expression promotes U87 glioblastoma invasion in vitro. Int J Dev Neurosci 17:463-472. (Pubitemid 29421833)
16. Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM, Law M, Flynn H, Passe S, Felten S, Brown PD, Shaw EG, Buckner JC. 2006. A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66:9852-9861. (Pubitemid 44672036)
17. Joshi PG, Mishra S. 1992. Galactocerebroside mediates Ca2+ signaling in cultured glioma cells. Brain Res 597:108-113.
18. Kitange G, Misra A, Law M, Passe S, Kollmeyer TM, Maurer M, Ballman K, Feuerstein BG, Jenkins RB. 2005. Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas. Genes Chromosomes Cancer 42:68-77. (Pubitemid 39582821)
19. Kitange GJ, Templeton KL, Jenkins RB. 2003. Recent advances in the molecular genetics of primary gliomas. Curr Opin Oncol 15:197-203. (Pubitemid 36735172)
20. Kost-Alimova M, Fedorova L, Yang Y, Klein G, Imreh S. 2004. Microcell-mediated chromosome transfer provides evidence that polysomy promotes structural instability in tumor cell chromosomes through asynchronous replication and breakage within late-replicating regions. Genes Chromosomes Cancer 40:316-324. (Pubitemid 38902542)
21. Law ME, Templeton KL, Kitange G, Smith J, Misra A, Feuerstein BG, Jenkins RB. 2005. Molecular cytogenetic analysis of chromosomes 1 and 19 in glioma cell lines. Cancer Genet Cytogenet 160:1-14. (Pubitemid 40798130)
22. Louis DN, Holland EC, Cairncross JG. 2001. Glioma classification: A molecular reappraisal. Am J Pathol 159:779-786.
23. Mathioudaki K, Scorilas A, Papadokostopoulou A, Xynopoulos D, Arnogianaki N, Agnanti N, Talieri M. 2004. Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer. Biol Chem 385:779-783. (Pubitemid 39335299)
24. Padalecki SS, Johnson-Pais TL, Killary AM, Leach RJ. 2001. Chromosome 18 suppresses the tumorigenicity of prostate cancer cells. Genes Chromosomes Cancer 30:221-229. (Pubitemid 32126197)
25. Perry A, Fuller CE, Banerjee R, Brat DJ, Scheithauer BW. 2003. Ancillary FISH analysis for 1p and 19q status: Preliminary observations in 287 gliomas and oligodendroglioma mimics. Front Biosci 8:a1-a9. (Pubitemid 39069937)
26. Quaye L, Dafou D, Ramus SJ, Song H, Gentry Maharaj A, Notaridou M, Hogdall E, Kruger Kjaer S, Christensen L, Hogdall C, Easton DF, Jacobs I, Menon U, Pharoah PD, Gayther SA. 2009. Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival. Hum Mol Genet 18:1869-1878.
27. Reifenberger G, Louis DN. 2003. Oligodendroglioma: Toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 62:111-126. (Pubitemid 36176946)
28. Rousseau A, Nutt CL, Betensky RA, Iafrate AJ, Han M, Ligon KL, Rowitch DH, Louis DN. 2006. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: Use of YKL-40, ApoE, ASCL1, and NKX2-2. J Neuropathol Exp Neurol 65:1149-1156. (Pubitemid 44888831)
29. Smith JS, Jenkins RB. 2000. Genetic alterations in adult diffuse glioma: Occurrence, significance, and prognostic implications. Front Biosci 5:D213-D231.
30. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB. 2000. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636-645. (Pubitemid 30078545)
31. Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW, Jenkins RB. 1999. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 18:4144-4152. (Pubitemid 29363922)
32. Stegh AH, Kim H, Bachoo RM, Forloney KL, Zhang J, Schulze H, Park K, Hannon GJ, Yuan J, Louis DN, DePinho RA, Chin L. 2007. Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma. Genes Dev 21:98-111. (Pubitemid 46089711)
33. Tews B, Felsberg J, Hartmann C, Kunitz A, Hahn M, Toedt G, Neben K, Hummerich L, von Deimling A, Reifenberger G, Lichter P. 2006. Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling. Int J Cancer 119:792-800. (Pubitemid 44051441)
34. Thomadaki H, Talieri M, Scorilas A. 2007. Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer. Cancer Lett 247:48-55. (Pubitemid 44959407)
35. Tsuji A, Kikuchi Y, Sato Y, Koide S, Yuasa K, Nagahama M, Matsuda Y. 2006. A proteomic approach reveals transient association of reticulocalbin-3, a novel member of the CREC family, with the precursor of subtilisin-like proprotein convertase, PACE4. Biochem J 396:51-59. (Pubitemid 43764496)
36. Valster A, Tran NL, Nakada M, Berens ME, Chan AY, Symons M. 2005. Cell migration and invasion assays. Methods 37:208-215.
37. van den Bent MJ. 2004. Advances in the biology and treatment of oligodendrogliomas. Curr Opin Neurol 17:675-680.
38. Vranova V, Necesalova E, Kuglik P, Cejpek P, Pesakova M, Budinska E, Relichova J, Veselska R. 2007. Screening of genomic imbalances in glioblastoma multiforme using high-resolution comparative genomic hybridization. Oncol Rep 17:457-464.